Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
Phillips also named President of Altemia & Co., a Lobe Sciences Company ... | June 7, 2023
Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phillips also named President of Altemia & Co., a Lobe Sciences Company ... | June 7, 2023
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has appointed Baxter Phillips III to the newly created position of chief operating officer (COO) effective...
17.05.2023 - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ('Lobe' or the 'Company'), a biopharmaceutical company focused on developing transformative medicines to treat orphan diseases today announced it has entered into a commercial distribution agreement for ... Seite 1
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical Company committed to discovering
Orphan and rare diseases drug company Lobe Sciences Ltd. LOBEF is set to acquire Altemia & Company LLC. The deal includes all Altemnia assets, intellectual…